Entera Bio Income Statement (2017-2026) | ENTX

Income Statement Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.11M0.14M0.17M0.07M0.04M0.01M0.01M0.06M0.04M0.08M0.04M
Cost of Revenue (Quarter)
0.10M0.07M0.14M0.05M0.03M0.01M0.01M0.05M0.04M0.08M0.04M
Gross Profit (Quarter)
0.01M0.07M0.03M0.01M0.01M0.00M0.01M0.01M
Operating items
Research & Development (Quarter)
1.23M1.77M2.65M1.69M1.39M1.41M1.35M0.93M1.21M1.37M1.00M0.73M1.09M1.48M1.20M1.12M1.52M1.64M1.72M2.25M
Selling, General & Administrative (Quarter)
1.36M1.53M1.48M2.17M1.88M1.46M1.74M1.29M1.14M1.03M0.97M1.33M1.09M1.54M1.14M1.44M1.15M1.61M1.32M1.29M
Other Operating Expenses (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Operating Expenses (Quarter)
2.58M3.29M4.12M3.85M3.26M2.87M3.07M2.21M2.33M2.39M1.96M2.06M2.17M3.02M2.34M2.56M2.67M3.26M3.04M3.54M
Operating Income (Quarter)
-2.57M-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M
EBIT (Quarter)
-2.57M-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M
Non-operating items
Other Non Operating Income (Quarter)
-0.04M
Non Operating Income (Quarter)
-0.02M-0.01M-0.03M0.04M0.06M-0.01M-0.01M0.02M0.01M0.04M-0.03M0.04M0.02M-0.01M-0.00M0.01M0.06M0.03M0.03M
Net income details
EBT (Quarter)
-2.59M-3.23M-4.12M-3.79M-3.19M-2.87M-3.08M-2.19M-2.33M-2.35M-2.00M-2.06M-2.44M-3.02M-2.34M-2.62M-2.73M-3.43M-3.14M-3.61M
Tax Provisions (Quarter)
-0.02M-0.01M-0.01M-0.01M-0.00M0.19M-0.05M0.03M0.01M
Profit After Tax (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.02M-2.15M-3.02M-2.36M-2.57M-2.66M-3.20M-3.02M-3.50M
Income from Continuing Operations (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M
Consolidated Net Income (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M
Income towards Parent Company (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M
Net Income towards Common Stockholders (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M
Additional items
EPS (Basic) (Quarter)
-0.10-0.11-0.16-0.13-0.11-0.11-0.11-0.08-0.08-0.08-0.07-0.06-0.07-0.08-0.06-0.06-0.06-0.07-20.96-0.08
EPS (Diluted) (Quarter)
-0.10-0.11-0.16-0.13-0.11-0.11-0.11-0.08-0.08-0.08-0.07-0.06-0.07-0.08-0.06-0.06-0.06-0.07-0.07-0.08
Shares Outstanding (Quarter)
24.72M28.68M26.13M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M36.74M37.09M37.64M37.65M43.38M46.84M47.09M0.15M47.76M
Shares Outstanding (Diluted) (Quarter)
24.72M28.68M26.13M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M36.74M37.09M37.64M37.65M43.38M46.84M47.09M46.19M47.76M
Shares Outstanding (Entity) (Quarter)
28.29M28.78M28.80M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M35.53M36.31M36.51M38.84M45.42M45.45M45.66M0.15M46.62M
EBITDA (Quarter)
-2.57M-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M
Interest Expenses (Quarter)
15.03M17.64M0.54M0.48M19.47M0.23M0.03M0.12M0.06M0.03M0.13M0.11M0.07M
Tax Rate (Quarter)
0.66%0.40%0.36%0.18%0.13%-6.75%1.49%-1.23%-0.60%